Roundtable Discussion: Learning From Migraine: How Better Biology, Endpoints & Patient Selection Can Improve Success in Pain Drug Development

3:00 pm - Thursday 28th January 2027

Exploring why migraine has become one of the most successful neuroscience therapeutic areas while many pain programs continue to fail
Examining how mechanism-driven development, including CGRP and emerging PACAP pathways, transformed clinical success in migraine and reshaped the treatment landscape
Applying lessons from migraine around patient stratification, endpoint selection and translational biomarkers to improve the probability of success in chronic pain indications
Identifying which elements of the migraine development playbook can accelerate innovation across neuropathic, musculoskeletal and chronic pain populations